|
Market Closed -
Other stock markets
|
After market 06:31:37 pm | |||
| 108.8 USD | +0.89% |
|
110.9 | +1.91% |
| Apr. 24 | Sector Update: Health Care Stocks Slipping Late Afternoon | MT |
| Apr. 24 | Moderna to Collaborate With OpenAI to Launch New Generation of Medicines | MT |
June 23 (Reuters) - U.S. Centers for Disease Control and Prevention's Panel:
* U.S. CDC ADVISERS RECOMMEND MODERNA'S COVID-19 VACCINE FOR CHILDREN AGED 6-11 YEARS
* U.S. CDC ADVISERS RECOMMEND MODERNA'S COVID-19 VACCINE FOR ADOLESCENTS AGED 12-17 YEARS Further company coverage:
| 1st Jan change | Capi. | |
|---|---|---|
| +9.45% | 41.31B | |
| +4.09% | 43.43B | |
| +47.81% | 41.69B | |
| -10.92% | 27.14B | |
| +9.32% | 25.28B | |
| -24.87% | 18.47B | |
| +29.70% | 12.59B | |
| +1.28% | 12.33B | |
| +7.78% | 11.03B | |
| -17.68% | 10.01B |
MODERNA, INC. 
